Placebo Intravenous Injection

DRUG3 trials

Sponsors

Novartis Pharmaceuticals, Dermama Bioteknologi Laboratorium, Olawumi Olajide

Conditions

HydrocelesInguinal HerniaMajor Depressive Disorder With Suicidal Ideation With IntentSARS-CoV2 InfectionSurgical Site Infection

Phase 2

Study of Efficacy and Safety of MIJ821 in Addition to Comprehensive Standard of Care on the Rapid Reduction of Symptoms of Major Depressive Disorder in Subjects Who Have Suicidal Ideation With Intent

TerminatedNCT04722666

Novartis PharmaceuticalsMajor Depressive Disorder With Suicidal Ideation With Intent

Start: 2021-07-20End: 2023-09-26Updated: 2026-05-18

Efficacy and Safety of EXOSOME-MSC Therapy to Reduce Hyper-inflammation In Moderate COVID-19 Patients

Dermama Bioteknologi LaboratoriumSARS-CoV2 Infection

Start: 2021-07-01End: 2022-12-30Target: 60Updated: 2022-02-18

Unknown Phase

Prevention of Surgical Site Infection in Open Paediatric Groin Surgeries Using Intravenous Prophylactic Antibiotics and Antimicrobial-coated Sutures

RecruitingNCT07346742

Olawumi OlajideHydroceles, Inguinal Hernia, Surgical Site Infection

Start: 2025-03-09End: 2026-02-27Target: 174Updated: 2026-01-16